Status:

Do Not Prescribe (DNP), Red

Decision Date:

September 2019

Comments

RED:

• NICE TA592: for treating metastatic or locally advanced cutaneous squamous cell carcinoma.  (NHSE commissioned).  (Decision date - September 2019).
• NICE TA802: for treating advanced cutaneous squamous cell carcinoma. (NHSE commissioned).  (Decision date - July 2022).

DNP: 

• NICE TA848: for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal) (Decision date - January 2023)
• NICE TA901 - Cemiplimab for treating recurrent or metastatic cervical cancer (Terminated appraisal) (Decision date - July 2023)

 

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again